Radiographic Progression Without Corresponding Prostate-specific Antigen Progression in Patients with Metastatic Castration-sensitive Prostate Cancer Receiving Apalutamide: Secondary Analysis of the TITAN TrialWataru Fukuokaya, Takahiro Kimura, Takafumi Yanagisawa et al.|European Urology Oncology|2024Cited by 25
Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone‐sensitive prostate cancer: A multicenter studyTakafumi Yanagisawa, Takahiro Kimura, Kojiro Tashiro et al.|The Prostate|2024Cited by 19
Locations of metastases in and oncological outcomes of patients with metastatic castration-sensitive prostate cancer: Real-world data from a multicenter studyFumihiko Urabe, Takahiro Kimura, Kojiro Tashiro et al.|Urologic Oncology Seminars and Original Investigations|2025Cited by 11
First-line therapy for metastatic renal cell carcinoma: A propensity score-matched comparison of efficacy and safetyTakafumi Yanagisawa, Takahiro Kimura, Keiichiro Mori et al.|Urologic Oncology Seminars and Original Investigations|2024Cited by 7
Effect of a variant histology on the oncological outcomes of Japanese patients with upper tract urothelial carcinomas after radical nephroureterectomy: a multicenter retrospective studyTakahiro Kimura, Naoki Uchida, Fumihiko Urabe et al.|Translational Andrology and Urology|2024Cited by 5